Mr. Devon D Peterson, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 3043 Ne 28th St, Lincoln City, OR 97367 Phone: 541-994-3661 |
Paul S. Palmer, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 3043 Ne 28th St, Lincoln City, OR 97367 Phone: 541-996-7152 Fax: 541-996-7120 |
Katie Elliott, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 3043 Ne 28th St, Lincoln City, OR 97367 Phone: 541-994-3661 |
News Archive
Pulmonary embolism - the sudden blockage of an artery in the lung - is estimated to cause over 100,000 deaths each year in the U.S. Although thrombolytics, or "clot-buster" drugs, are currently reserved to treat only the most severe cases of pulmonary embolism, new data suggest that when used at lower doses, these drugs are also safe and effective for more common, moderate cases of pulmonary embolism, according to research presented today at the American College of Cardiology's 61st Annual Scientific Session.
Cyberonics, Inc. announced today that the VNS Therapy System, the only FDA-approved implantable medical device for the treatment of refractory epilepsy, was featured in 22 poster presentations and in the Plenary II session on neurostimulation at the annual American Epilepsy Society Meeting that took place recently in San Antonio, Texas.
Dead crows found in Stephenson and Winnebago counties have tested positive for West Nile virus, Dr. Eric E. Whitaker, state public health director, today reported.
Lack of sleep can make you sick. And while everybody has the occasional restless night, for those who suffer from chronic insomnia — some 15 percent of older adults in the United States — that sleep loss can increase the risk for cardiovascular disease, hypertension, weight gain, type 2 diabetes, and even lead to an earlier death.
Building on the results of a recent Cedars-Sinai Heart Institute study published just six months ago, the Department of Defense has awarded a $10 million grant to fund a cardiac cell therapy trial for patients diagnosed with a common but difficult-to-treat form of heart failure.
› Verified 2 days ago